Pediatric Jaundice
Pediatric/Neonatal
jaundice is a yellowish discoloration of the white part of the eyes and skin in
a newborn baby due to high bilirubin levels. Other symptoms may include surplus
sleepiness or poor feeding. Difficulties may include seizures, cerebral palsy,
or kernicterus.
In
many cases there is no specific underlying disorder (physiologic). In other
cases it significances from red blood cell cessation, liver disease, infection,
hypothyroidism, or metabolic complaints (pathologic). A bilirubin level more
than 34 μmol/l (2 mg/dL) may be visible. Concerns, in otherwise healthy babies,
occur when levels are greater than 308 μmol/L (18 mg/dL), jaundice is noticed
in the first day of life, there is a quick rise in levels, jaundice lasts more
than two weeks, or the baby appears unwell. In those with concerning findings
further investigations to determine the underlying cause are recommended.
The
need for treatment depends on bilirubin levels, the age of the child, and the
underlying cause. Treatments may include more frequent feeding, phototherapy,
or exchange transfusions.
Causes
In
neonates, jaundice tends to progress because of two factors—the breakdown of
fetal hemoglobin as it is swapped with adult hemoglobin and the relatively
immature metabolic pathways of the liver, which are unable to conjugate and so defecate
bilirubin as quickly as an mature. This causes an accumulation of bilirubin in
the blood (hyperbilirubinemia), leading to the signs of jaundice.
If
the neonatal jaundice does not resolve with simple phototherapy, other causes
such as biliary atresia, Progressive familial intrahepatic cholestasis, bile
duct paucity, Alagille syndrome, alpha 1-antitrypsin deficiency, and other
pediatric liver diseases should be considered.Submit your Abstract in WCPNN 2019 Conference!!Abstract submission link: https://pediatric.nursingmeetings.com/abstract- submission.phpRegister as soon as Possible to avail early Bird registration on/before Dec 10, 2018Visit Website: https://pediatric.nursingmeetings.com/
No comments:
Post a Comment